Finding 1137566 (2023-007)

Significant Deficiency
Requirement
AB
Questioned Costs
-
Year
2023
Accepted
2025-05-20

AI Summary

  • Core Issue: PHIMC lacks proper documentation to confirm compliance with subrecipient monitoring policies.
  • Impacted Requirements: The absence of formal agreements and incomplete documentation risks non-compliance with federal program terms.
  • Recommended Follow-Up: PHIMC should review and enhance monitoring policies and ensure all documentation is complete and accessible.

Finding Text

Agencies: U.S. Department of Health and Human Services Pass-through Agency: Illinois Department of Public Health Federal program: 93.940 HIV Prevention Activities-Health Department Based Criteria: The Uniform Guidance requires passthrough entities to provide reasonable assurance that the subrecipient administered the subaward in compliance with the terms and conditions of the subaward. In addition, passthrough entities should have comprehensive monitoring policies and procedures in place which is risk based. Condition: PHIMC has subrecipient monitoring policies and procedures, but there is a lack of documentation in place to determine if those policies and procedures are being completely followed as well as lack of documentation of the monitoring. In addition, formal agreements between PHIMC and the subrecipient were not located for all subrecipients. Context: PHIMC provides funding to approximately 10-12 subrecipients. Cause: As a result of turnover in the finance department not all documentation could be found and certain documentation was not completed in full. Questions Costs: None. Effect: There is a risk the terms and conditions of all awards provided to subrecipients are not in compliance with the terms and conditions of the award. Recommendation: We recommend PHIMC evaluate their current subrecipient monitoring policies andprocedures and ensure they are comprehensive and actual monitoring is documented. Views of Responsible Officials: In conjunction with the hiring of a professional services firm for accounting and finance support, PHIMC will evaluate subrecipient monitoring policies and procedures

Categories

Subrecipient Monitoring

Other Findings in this Audit

  • 561096 2023-002
    Significant Deficiency
  • 561097 2023-004
    Significant Deficiency
  • 561098 2023-005
    Significant Deficiency
  • 561099 2023-002
    Significant Deficiency
  • 561100 2023-004
    Significant Deficiency
  • 561101 2023-005
    Significant Deficiency
  • 561102 2023-002
    Significant Deficiency
  • 561103 2023-004
    Significant Deficiency
  • 561104 2023-005
    Significant Deficiency
  • 561105 2023-002
    Significant Deficiency
  • 561106 2023-004
    Significant Deficiency
  • 561107 2023-005
    Significant Deficiency
  • 561108 2023-006
    Significant Deficiency
  • 561109 2023-007
    Significant Deficiency
  • 561110 2023-002
    Significant Deficiency
  • 561111 2023-004
    Significant Deficiency
  • 561112 2023-005
    Significant Deficiency
  • 561113 2023-006
    Significant Deficiency
  • 561114 2023-007
    Significant Deficiency
  • 561115 2023-002
    Significant Deficiency
  • 561116 2023-004
    Significant Deficiency
  • 561117 2023-005
    Significant Deficiency
  • 561118 2023-006
    Significant Deficiency
  • 561119 2023-007
    Significant Deficiency
  • 561120 2023-002
    Significant Deficiency
  • 561121 2023-004
    Significant Deficiency
  • 561122 2023-005
    Significant Deficiency
  • 561123 2023-006
    Significant Deficiency
  • 561124 2023-007
    Significant Deficiency
  • 561125 2023-002
    Significant Deficiency
  • 561126 2023-004
    Significant Deficiency
  • 561127 2023-005
    Significant Deficiency
  • 561128 2023-002
    Significant Deficiency
  • 561129 2023-004
    Significant Deficiency
  • 561130 2023-005
    Significant Deficiency
  • 561131 2023-002
    Significant Deficiency
  • 561132 2023-004
    Significant Deficiency
  • 561133 2023-005
    Significant Deficiency
  • 1137538 2023-002
    Significant Deficiency
  • 1137539 2023-004
    Significant Deficiency
  • 1137540 2023-005
    Significant Deficiency
  • 1137541 2023-002
    Significant Deficiency
  • 1137542 2023-004
    Significant Deficiency
  • 1137543 2023-005
    Significant Deficiency
  • 1137544 2023-002
    Significant Deficiency
  • 1137545 2023-004
    Significant Deficiency
  • 1137546 2023-005
    Significant Deficiency
  • 1137547 2023-002
    Significant Deficiency
  • 1137548 2023-004
    Significant Deficiency
  • 1137549 2023-005
    Significant Deficiency
  • 1137550 2023-006
    Significant Deficiency
  • 1137551 2023-007
    Significant Deficiency
  • 1137552 2023-002
    Significant Deficiency
  • 1137553 2023-004
    Significant Deficiency
  • 1137554 2023-005
    Significant Deficiency
  • 1137555 2023-006
    Significant Deficiency
  • 1137556 2023-007
    Significant Deficiency
  • 1137557 2023-002
    Significant Deficiency
  • 1137558 2023-004
    Significant Deficiency
  • 1137559 2023-005
    Significant Deficiency
  • 1137560 2023-006
    Significant Deficiency
  • 1137561 2023-007
    Significant Deficiency
  • 1137562 2023-002
    Significant Deficiency
  • 1137563 2023-004
    Significant Deficiency
  • 1137564 2023-005
    Significant Deficiency
  • 1137565 2023-006
    Significant Deficiency
  • 1137567 2023-002
    Significant Deficiency
  • 1137568 2023-004
    Significant Deficiency
  • 1137569 2023-005
    Significant Deficiency
  • 1137570 2023-002
    Significant Deficiency
  • 1137571 2023-004
    Significant Deficiency
  • 1137572 2023-005
    Significant Deficiency
  • 1137573 2023-002
    Significant Deficiency
  • 1137574 2023-004
    Significant Deficiency
  • 1137575 2023-005
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.940 Hiv Prevention Activities Health Department Based $155,102
93.959 Block Grants for Prevention and Treatment of Substance Abuse $145,670
93.145 Aids Education and Training Centers $105,890
94.006 Americorps State and National 94.006 $8,945